CE Instructions for
WB4687: Immunization:  You Call the Shots-Module Four-Haemophilus influenzae type b (Hib) 2023
(Credit expires 7/17/2025)

Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WB4687: Immunization:  You Call the Shots-Module Four-Haemophilus influenzae type b (Hib) 2023, please visit CDC TRAIN and search for the course in the Course Catalog using WB4687. Follow the steps below by 7/17/2025.

1.         Register for and complete the course.
2.         Pass the post-assessment at 80%.
3.         Complete the evaluation.
4.         Visit “Your Learning” to access your certificates and transcript.
NOTE—You must pass the posttest at 80%. There are only 2 attempts allowed.

If you have any questions or problems, contact CDC TRAIN via email at TRAIN@cdc.gov. You may also contact the CE Coordinator at NCIRD, Melissa Barnett, at MBarnett2@cdc.gov.

PROGRAM DESCRIPTION: You Call the Shots is an interactive, web-based immunization training course. It consists of a series of modules that discuss vaccine-preventable diseases and explain the latest recommendations for vaccine use. Each module provides learning opportunities, self-test practice questions, reference and resource materials, and an extensive glossary. This fourth module in the series discusses haemophilus influenzae type b (Hib) disease and its related vaccine.

OBJECTIVES: At the conclusion of the session, the participant will be able to:
For Haemophilus influenzae type b (Hib), describe this disease, including the causative agent.
For Haemophilus influenzae type b (Hib), list the groups at highest risk.
For Haemophilus influenzae type b (Hib), identify those for whom routine immunization is recommended.
For Haemophilus influenzae type b (Hib), describe characteristics of the vaccine used to prevent this disease.
Locate current immunization resources to increase knowledge of team’s role in program implementation for improved team performance.

M. Suzanne Johnson-DeLeon, MPH, Health Education and Information Specialist, CDC/NCIRD
Kroger, Andrew MD, MPH, Medical Officer, CDC, NCIRD

ORIGINATION DATE: 7/17/2023                                                                                                     EXPIRATION DATE: 7/17/2025
URL: https://www2a.cdc.gov/nip/isd/ycts/mod1/courses/hib/ce.asp
HARDWARE/SOFTWARE: Computer Hardware; Internet connection; Browser; MATERIALS: None
TARGET AUDIENCE: Administrators, CHES certified health educators, Physicians, Epidemiologists, LPNs, LVNs, Medical assistants, medical students, NPs, nurse technicians, other health educators, Pharmacists, PAs, program managers RNs
PREREQUISITES: Participants should have a basic educational background in science including general knowledge in the subject areas of biology, immunization, and vaccine-preventable diseases.

FORMAT: This course is Enduring material.
CE Logo In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME:  The Centers for Disease Control and Prevention designates this Enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA CME–Credit Designation Statement – Enduring:  The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 7/17/2025. PAs should only claim credit commensurate with the extent of their participation.

CNE:  The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this knowledge-based event for pharmacists to receive 1 CEUs (1 contact hours) in pharmacy education. The Universal Activity Number is JA4008229-0000-23-060-H06-P.

After credit is claimed, an unofficial statement of credit is immediately available on CDC TRAIN. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

CEU:  The Centers for Disease Control and Prevention is authorized by IACET to offer .1 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.

For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a preapproved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.  

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of the presenters’ discussion on Hib vaccines. Presenters will be discussing Hib vaccines in a manner recommended by the Advisory Committee on Immunization Practices, but not approved by the Food and Drug Administration.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
FEES: No fees are charged for CDC’s CE activities.